address1,city,zip,country,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,enterpriseToRevenue,52WeekChange,SandP52WeekChange,quoteType,currentPrice,recommendationKey,totalCash,totalCashPerShare,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,epsTrailingTwelveMonths,epsForward,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,regularMarketChange,regularMarketDayRange,isEarningsDateEstimate,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,hasPrePostMarketData,fiftyTwoWeekChangePercent,firstTradeDateMilliseconds,cryptoTradeable,regularMarketChangePercent,regularMarketPrice,shortName,longName,marketState,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,trailingPegRatio
Box 12040,Stockholm,112 40,Sweden,https://www.liddspharma.com,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"LIDDS AB (publ), a drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden. Its product pipeline comprises Nanoimod, a NanoZolid-formulated agatolimod, as well as a toll-like receptor 9 (TLR9) agonist, which is in preclinical trial; Nanodotax, a NanoZolid-formulated docetaxel, which is a chemotherapy medication that is approved for various oncological condition, such as breast cancer, head and neck cancer, and prostate cancer; and NOV202, which is in clinical Phase Ib/IIa study to treat refractory cancer. The company also develops Liproca Depot, a NanoZolid-formulated 2-hydroxyltutamide (2-HOF), which is an anti-androgen drug for treating prostate cancer patients before radical treatments. It also has a research and development agreement with Johnson & Johnson Enterprise Innovation Inc. to develop oncology products based on the NanoZolid technology for a non-disclosed indication. The company was incorporated in 1999 and is based in Stockholm, Sweden.",1,"[{'maxAge': 1, 'name': 'Mats  Wiking', 'age': 55, 'title': 'CEO, CFO & Head of IR', 'yearBorn': 1969, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Monica  Wallter', 'age': 68, 'title': 'Senior Advisor', 'yearBorn': 1956, 'fiscalYear': 2021, 'totalPay': 1872000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kia  Bengtsson', 'age': 55, 'title': 'Head of Clinical Development', 'yearBorn': 1969, 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Roger  Belusa', 'title': 'Chief Medical Officer', 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}]",1640908800,[],86400,4,0.0896,0.0896,0.0886,0.0896,0.0896,0.0896,0.0886,0.0896,0.0,0.267,-0.1772,20250,20250,216954,36201,36201,0.0308,0.0756,0,0,12281732,0.0304,0.23,1364.6368,0.054488,0.099074,0.0,0.0,SEK,False,4375043,0.0,66373032,136463008,0.61726004,0.05377,138620000,0.024,3.6916668,1735603200,1767139200,1743379200,-7244000,-0.05,-0.5,486.116,-0.37323946,0.10611236,EQUITY,0.0886,none,4768000,0.035,0,3.503,3.61,9000,0.0,-0.46660998,-1.0791,-4155000,-4879875,-6108000,0.0,0.0,-793.77783,SEK,LIDDS.ST,en-US,US,Equity,Delayed Quote,True,HIGH,-0.05,-0.5,1756378740,1756378740,1756378740,-0.0009999946,0.0886 - 0.0896,False,1.9144737,0.0304 - 0.23,-0.14140001,-0.61478263,0.034112003,0.6260462,-0.010473996,-0.105718926,15,0,Stockholm,216954,0.0582,False,-37.323944,1406790000000,False,-1.1160654,0.0886,LIDDS AB,LIDDS AB (publ),PREPRE,[],1752766196,STO,finmb_33303256,Europe/Stockholm,CEST,7200000,se_market,False,
